首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

2007982

阿片类药物使用障碍 (OUD) 市场：按产品类型、给药途径、剂型、性别、品牌、年龄层、类型、适应症、分销管道和地区划分

Opioid Use Disorder Market, By Product Type, By Route of Administration, By Dosage Form, By Availability, By Brand, By Age Group, By Type, By Indication, By Distribution Channel, By Geography

出版日期: 2026年03月11日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

据估计，2026年阿片类药物使用障碍（OUD）市场规模为63.034亿美元，预计到2033年将达到98.602亿美元。预计从2026年到2033年，该市场将以9.4%的复合年增长率成长。

报告范围		报告详情
基准年：	2025	2026年市场规模：	63.034亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
2026年至2033年预测期间的复合年增长率：	9.40%	2033年市场规模预测：	98.602亿美元

全球阿片类药物使用障碍 (OUD) 市场是一个至关重要的医疗保健领域，它正努力应对当今最紧迫的公共卫生危机之一。 OUD 的特征是儘管存在有害后果，仍会强迫性地使用鸦片类药物，这是一种慢性疾病。 OUD 影响着全球数百万人，并给医疗保健系统、家庭和社区带来沉重的社会经济负担。该市场涵盖多种治疗介入措施，包括美沙酮、Buprenornhine和纳曲酮等辅助性治疗(MAT)，以及综合行为疗法和支持治疗性介入。由于全球数十万人死于阿片类药物过量，成瘾率持续上升，对有效治疗方案的需求正在显着增长。

受循证治疗方法认知度提高、政府促进医疗服务可及性的倡议以及对成瘾作为一种需要专业干预的合法疾病的污名化现象的减少等因素的推动，该市场正经历显着增长。医疗服务提供者、製药公司和政策制定者正携手合作，开发创新治疗方法，扩大医疗服务覆盖范围，并实施减少危害的策略。数位健康科技、远端医疗平台和个人化治疗方案的整合，正在进一步改变产业格局，为患者参与和优化治疗方案以应对这一复杂疾病提供了新的机会。

市场动态

全球阿片类药物使用障碍（OUD）市场的主要驱动力是全球阿片类药物成瘾盛行率的激增，处方阿片类药物滥用和非法药物使用在已开发国家和开发中国家均已达到流行病的程度。政府措施和政策改革，例如扩大医疗补助覆盖范围和取消药物成瘾治疗（MAT）的预先核准要求，正在显着推动循证治疗方法的普及，从而显着促进市场成长。随着人们对成瘾的认知从道德缺陷转变为可治疗的疾病，社会歧视正在减少，越来越多的人开始寻求专业协助。治疗服务的技术进步，例如远端医疗平台、行动医疗应用程式和远端监测系统，提高了治疗的可近性和依从性，尤其是在服务不足的农村地区。

然而，该市场面临许多限制因素，包括围绕成瘾治疗的持续污名化、某些地区医疗基础设施不足以及综合治疗项目保险覆盖范围有限。监管的复杂性和特定药物严格的处方要求对医疗服务提供者和患者都构成了障碍。合格的成瘾专家和治疗机构的匮乏，尤其是在遍远地区，严重限制了人们获得医疗服务的机会。此外，长期治疗计画的高成本以及不同医疗体系之间缺乏标准化的治疗通讯协定，也对市场扩张构成挑战。

儘管如此，透过开发新型治疗方法，例如长效注射剂和预防滥用药物，仍存在巨大的成长机会。日益重视将医疗和行为健康服务结合的综合护理模式，也显示了其巨大的成长潜力。官民合作关係以及对成瘾研究、开发和治疗基础设施投入的增加，为市场扩张提供了一个有希望的途径。

本次调查的主要特点。

本报告对全球阿片类药物使用障碍 (OUD) 市场进行了详细分析，以 2025 年为基准年，给出了预测期 (2026-2033) 的市场规模和復合年增长率 (%)。
本报告指出了各个细分市场的潜在商机，并说明了该市场中具有吸引力的投资提案矩阵。
此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
本报告根据以下参数分析了全球阿片类药物使用障碍 (OUD) 市场的主要参与者：公司概况、产品系列、主要亮点、财务绩效和策略。
透过利用本报告中提出的见解，企业行销负责人和经营团队可以就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过分析全球阿片类药物使用障碍 (OUD) 市场中使用的各种策略矩阵轻鬆做出决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
其他欧洲国家
亚太地区
中国
印度
日本
澳洲
韩国
ASEAN
亚太其他地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第十四章竞争格局

Indivior
Braeburn
Camurus
Alkermes
Emergent BioSolutions
Orexo
Hikma Pharmaceuticals
Dr Reddy's Laboratories
Alvogen
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Viatris
Teva Pharmaceuticals
Sandoz
Kaleo

第十五章分析师建议

机会
分析师意见
连贯的机会地图

第十六章参考文献与调查方法

参考
调查方法
关于本公司

简介目录

Product Code: CMI4597

Opioid Use Disorder Market is estimated to be valued at USD 6,303.4 Mn in 2026 and is expected to reach USD 9,860.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 6,303.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.40%	2033 Value Projection:	USD 9,860.2 Mn

The global opioid use disorder market represents a critical healthcare segment addressing one of the most pressing public health crises of the modern era. Opioid use disorder is characterized as a chronic medical condition involving the compulsive use of opioids despite harmful consequences, affecting millions of individuals worldwide and imposing substantial socioeconomic burdens on healthcare systems, families, and communities. The market encompasses various therapeutic interventions including medication-assisted treatment (MAT) options such as methadone, buprenorphine, and naltrexone, alongside comprehensive behavioral therapies and support services. With opioid-related overdoses claiming hundreds of thousands of lives globally and addiction rates continuing to escalate, the demand for effective treatment solutions has intensified significantly.

The market has witnessed substantial growth driven by increasing awareness about evidence-based treatments, government initiatives promoting accessible healthcare, and the destigmatization of addiction as a legitimate medical condition requiring professional intervention. Healthcare providers, pharmaceutical companies, and policymakers are collectively working to develop innovative treatment modalities, expand access to care, and implement harm reduction strategies. The integration of digital health technologies, telemedicine platforms, and personalized treatment approaches has further transformed the landscape, offering new opportunities for patient engagement and treatment optimization in addressing this complex disorder.

Market Dynamics

The global opioid use disorder market is primarily driven by the escalating prevalence of opioid addiction worldwide, with prescription opioid misuse and illicit drug consumption reaching epidemic proportions across developed and developing nations. Government initiatives and policy reforms promoting evidence-based treatment approaches, including expanded Medicaid coverage and the elimination of prior authorization requirements for MAT, have significantly boosted market growth. The increasing recognition of addiction as a treatable medical condition rather than a moral failing has reduced stigma and encouraged more individuals to seek professional help. Technological advancements in treatment delivery, including telemedicine platforms, mobile health applications, and remote monitoring systems, have improved accessibility and treatment adherence, particularly in underserved rural areas.

However, the market faces substantial restraints including persistent stigma surrounding addiction treatment, limited healthcare infrastructure in certain regions, and inadequate insurance coverage for comprehensive treatment programs. Regulatory complexities and stringent prescribing requirements for certain medications create barriers for healthcare providers and patients. The shortage of qualified addiction specialists and treatment facilities, particularly in rural areas, significantly limits access to care. Additionally, the high cost of long-term treatment programs and the lack of standardized treatment protocols across different healthcare systems pose challenges to market expansion.

Nevertheless, significant opportunities exist through the development of novel therapeutic interventions, including long-acting injectable formulations and abuse-deterrent medications. The growing emphasis on integrated care models combining medical treatment with behavioral health services presents substantial growth potential. Public-private partnerships and increased funding for addiction research and treatment infrastructure development offer promising avenues for market expansion.

Key Features of the Study

This report provides in-depth analysis of the global opioid use disorder market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global opioid use disorder market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior, Braeburn, Camurus, Alkermes, Emergent BioSolutions, Orexo, Hikma Pharmaceuticals, Dr Reddy's Laboratories, Alvogen, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Teva Pharmaceuticals, Sandoz, and Kaleo
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Buprenorphine
- Oral
- Parenteral
- Others
- Naloxone
- Parenteral
- Others
- Naltrexone
- Oral
- Parenteral
- Combination Drugs
- Methadone
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Parenteral
- Extended-release Injection for Subcutaneous
- Intramuscular
- Oral
- Sublingual Tablet
- Sublingual Film
- Suspension
- Others
Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
- Injections
- Sublingual film
- Sublingual or Buccal
- Tablet
- Suspension
- Others
Availability Insights (Revenue, USD Mn, 2021 - 2033)
- Prescription
- Over the Counter
Brand Insights (Revenue, USD Mn, 2021 - 2033)
- Sublocade
- Suboxone
- Brixadi
- Vivitrol
- Zubsolv
- NARCAN
- Others
Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Adult
- Children
Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generic
Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Opioid Addiction
- Pain Management
- Acute
- Chronic
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Indivior
- Braeburn
- Camurus
- Alkermes
- Emergent BioSolutions
- Orexo
- Hikma Pharmaceuticals
- Dr Reddy's Laboratories
- Alvogen
- Sun Pharmaceutical Industries
- Amneal Pharmaceuticals
- Viatris
- Teva Pharmaceuticals
- Sandoz
- Kaleo

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Opioid Use Disorder Market, By Product Type
- Global Opioid Use Disorder Market, By Route of Administration
- Global Opioid Use Disorder Market, By Dosage Form
- Global Opioid Use Disorder Market, By Availability
- Global Opioid Use Disorder Market, By Brand
- Global Opioid Use Disorder Market, By Age Group
- Global Opioid Use Disorder Market, By Type
- Global Opioid Use Disorder Market, By Indication
- Global Opioid Use Disorder Market, By Distribution Channel
- Global Opioid Use Disorder Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Opioid Use Disorder Market, By Product Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Oral
  - Parenteral
  - Others
Naloxone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Parenteral
  - Others
Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Oral
  - Parenteral
Combination Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Opioid Use Disorder Market, By Route of Administration, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Extended-release Injection for Subcutaneous
  - Intramuscular
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Sublingual Tablet
  - Sublingual Film
  - Suspension
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Opioid Use Disorder Market, By Dosage Form, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Sublingual film
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Sublingual or Buccal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Opioid Use Disorder Market, By Availability, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Over the Counter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Opioid Use Disorder Market, By Brand, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Sublocade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Suboxone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Brixadi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Vivitrol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Zubsolv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
NARCAN
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Opioid Use Disorder Market, By Age Group, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global Opioid Use Disorder Market, By Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

11. Global Opioid Use Disorder Market, By Indication, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Acute
Chronic

12. Global Opioid Use Disorder Market, By Distribution Channel, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

13. Global Opioid Use Disorder Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

14. Competitive Landscape

Indivior
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braeburn
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Camurus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orexo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dr Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alvogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amneal Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viatris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sandoz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kaleo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

15. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

16. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

阿片类药物使用障碍 (OUD) 市场：按产品类型、给药途径、剂型、性别、品牌、年龄层、类型、适应症、分销管道和地区划分

Opioid Use Disorder Market, By Product Type, By Route of Administration, By Dosage Form, By Availability, By Brand, By Age Group, By Type, By Indication, By Distribution Channel, By Geography

市场动态

目录

第一章：研究目标与前提条件

第二章市场范围

第三章：市场动态、监管与趋势分析

第四章全球鸦片类药物使用障碍（OUD）市场：依产品类型划分，2021-2033年

第五章全球鸦片类药物使用障碍（OUD）市场：依给药途径划分，2021-2033年

第六章全球鸦片类药物使用疾患（OUD）市场：依剂型划分，2021-2033年

第七章全球阿片类药物使用障碍（OUD）市场：按性别分類的供应情况，2021-2033年

第八章全球鸦片类药物使用障碍（OUD）市场：依品牌划分，2021-2033年

第九章全球阿片类药物使用障碍（OUD）市场：按年龄划分，2021-2033年

第十章全球阿片类药物使用障碍（OUD）市场：按类型划分，2021-2033年

第十一章全球鸦片类药物使用障碍（OUD）市场：依适应症划分，2021-2033年

第十二章全球阿片类药物使用障碍（OUD）市场：依通路划分，2021-2033年

第十三章全球鸦片类药物使用障碍（OUD）市场：依地区划分，2021-2033年